Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area.
When was Somaxon's initial public offering (IPO)?
December 2005
Does Somaxon pay a dividend on its common stock?
As an emerging specialty pharmaceutical company, Somaxon has not declared a cash dividend on its common stock, nor does it presently have any plans to initiate a dividend program.
Does Somaxon have a direct stock purchase program?
Somaxon does not have a direct stock purchase program.
How many shares of common stock does Somaxon have outstanding?
As of March 31, 2009, Somaxon had approximately 18.4 million common shares outstanding.
When does Somaxon's fiscal year end?
Somaxon's fiscal year ends on December 31st.
Who is Somaxon's stock transfer agent?
American Stock Transfer, which may be reached at 59 Maiden Lane, New York, NY 10038, (212) 936-5100.
420 Stevens Avenue, Suite 210, Solana Beach, CA 92075
Somaxon's mailing address is:
3830 Valley Centre Drive, Suite 705-461
San Diego, CA 92130-3323
What is Somaxon's ticker symbol?
Somaxon's ticker symbol is SOMX and trades on the Nasdaq stock market.
When is Somaxon's next Annual Meeting of Stockholders?
The Annual Meeting of the Stockholders of Somaxon Pharmaceuticals, Inc. was held on June 9, 2009. The date and time of the 2010 meeting has not yet been announced.
Who can I contact for information about my shares, transfer of my shares, change of address or lost stock certificates?
Somaxon's transfer agent is American Stock Transfer, located at 59 Maiden Lane, New York, NY 10038. They may be reached at (212) 936-5100.
Who are the members of your senior management team?
Click here to access a directory of our management team.
Who is on your Board of Directors?
Click here to access a directory of our Board of Directors
